Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05034263 · ClinicalTrials.gov registry record
Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease
A clinical trial, sponsored by Stony Brook University.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05034263 is a clinical trial that was terminated before completion, run by Stony Brook University. The registered enrollment target is 6 participants.
The verdict
NCT05034263 was terminated before completion, sponsored by Stony Brook University.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This is an imaging study designed to illuminate the function of the cholinergic system and its association with cognitive skills in people with Parkinson's disease. The hypothesis of this study is that there will be an association between cholinergic terminal density, sex hormones, and cognitive functioning. Participants will receive a PET and MRI scan along with a battery of neurocognitive tests at baseline and again at 18 months follow-up. Hormone levels will be measured at baseline.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-05-27 |
| Est. Completion | 2024-05-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05034263
The ClinicalTrials.gov registry entry for NCT05034263 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05034263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05034263 about?
NCT05034263 is a clinical study titled "Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease". This is an imaging study designed to illuminate the function of the cholinergic system and its association with cognitive skills in people with Parkinson's disease. The hypothesis of this study is that there will be an association between cholinergic terminal density, sex hormones, and cognitive fun...
What is the current status of trial NCT05034263?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2021-05-27. Estimated completion is 2024-05-27.
Who is sponsoring clinical trial NCT05034263?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.